iCAD vs Nucleai
iCAD vs Nucleai, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: iCAD is on 55/100 and Nucleai on 63/100.
Where each one leads
iCAD
- domain rating: 53/100 against 29/100
- headcount: 353 against 66
- headcount growth: +26.6% against -7.0%
Nucleai
- our overall score: 63/100 against 55/100
- funding raised: $58.5M against $37.5M
At a glance
| Measure | iCAD | Nucleai |
|---|---|---|
| What it is | AI-powered cancer detection and therapy solutions for early diagnosis and personalized risk assessment. | AI-powered spatial biology platform for precision medicine and drug development. |
| Category | MedTech, HealthTech, AI-Driven Protein Design, Clinical Trials | Healthcare, Oncology, Pharmaceutical, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 1984 | 2018 |
| Headquarters | Nashua, United States | Tel Aviv, Israel |
| Status | Active | Active |
Size, funding and growth
| Measure | iCAD | Nucleai |
|---|---|---|
| Employees | 353 | 66 |
| Headcount growthLast 12 months | +26.6% | -7.0% |
| Total funding | $37.5M | $58.5M |
| Latest round | Direct Offering | Series B |
| LinkedIn followers | 15,268 | 18,902 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | iCAD | Nucleai |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 55/100 | 63/100 |
| Traction | 58/100 | 57/100 |
| Team | 50/100 | 70/100 |
| Community | Not published | 8/100 |
| Search visibility | 33/100 | 31/100 |
| Quality | 58/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (39/100) | D (42/100) |
| Domain ratingLink authority, 0-100 | 53/100 | 29/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | iCAD | Nucleai |
|---|---|---|
| CDN | Cloudflare | Not detected |
| CMS | Ghost | WordPress |
| Frameworks | Not detected | Jquery |
| Analytics | Not detected | Google Tag Manager, Linkedin Insight, Facebook Pixel |
| Support stack | Not detected | HubSpot |
iCAD vs Nucleai: common questions
Which is better, iCAD or Nucleai?
On our 0-100 score Nucleai rates higher (63/100 against 55/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do iCAD and Nucleai compare on the numbers?
iCAD leads on domain rating (53/100 against 29/100), headcount (353 against 66), headcount growth (+26.6% against -7.0%). Nucleai leads on our overall score (63/100 against 55/100), funding raised ($58.5M against $37.5M).
Read the full iCAD review and pricing or the Nucleai review and pricing. You can also browse other iCAD alternatives we track.